Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	SHP626 5 Milligram (mg)	0	49
Total, all-cause mortality	SHP626 10 Milligram (mg)	0	49
Total, all-cause mortality	SHP626 20 Milligram (mg)	0	49
Total, all-cause mortality	Placebo (PBO)	0	49
Total, other adverse events	SHP626 5 Milligram (mg)	44	49
Total, other adverse events	SHP626 10 Milligram (mg)	44	49
Total, other adverse events	SHP626 20 Milligram (mg)	42	49
Total, other adverse events	Placebo (PBO)	37	49
Total, serious adverse events	SHP626 5 Milligram (mg)	1	49
Total, serious adverse events	SHP626 10 Milligram (mg)	2	49
Total, serious adverse events	SHP626 20 Milligram (mg)	0	49
Total, serious adverse events	Placebo (PBO)	1	49

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02787304/event-totals